Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Indutrade AB ( (SE:INDT) ) has provided an announcement.
Indutrade AB has acquired the Italian medtech company SLT srl, which specializes in testing and safety control devices for the medical technology and healthcare sectors. This acquisition, expected to close in Q3 2025, will be part of Indutrade’s Business Area Life Science and is anticipated to have a marginally positive impact on the company’s earnings per share. The move strengthens Indutrade’s position in the medtech industry by adding SLT’s niche expertise and market presence.
The most recent analyst rating on (SE:INDT) stock is a Hold with a SEK325.00 price target. To see the full list of analyst forecasts on Indutrade AB stock, see the SE:INDT Stock Forecast page.
More about Indutrade AB
Indutrade is an international technology and industrial business group comprising over 200 companies across approximately 30 countries, primarily in Europe. The company focuses on sustainable profitable growth through the development and acquisition of successful companies in selected niches. Indutrade’s offerings include components, systems, and services with significant technical content. The group reported net sales of SEK 32.5 billion in 2024 and is listed on Nasdaq Stockholm.
Average Trading Volume: 307,001
Technical Sentiment Signal: Hold
Current Market Cap: SEK88.17B
For detailed information about INDT stock, go to TipRanks’ Stock Analysis page.